Thrombocytopenia has been acknowledged to be a crucial risk factor for cirrhosis formation
and hepatocarcinogenesis in chronic liver diseases. However, to date, the association …

Reliable biomarkers are of great clinical value in predicting cancer occurrence/recurrence,
anticipating its detection at an asymptomatic stage, supporting the radiological diagnosis …

Background and Aims Treatment of patients with Barcelona Clinic Liver Cancer Stage B
hepatocellular carcinoma (BCLC-B HCC) is controversial. This study compared the long …

Purpose To describe efficacy and safety of stereotactic body radiation therapy (SBRT) for the
treatment of inoperable hepatocellular carcinoma. Methods The records of 77 consecutive …

Objective: The aim of the study was to evaluate the survival benefits of liver resection (LR)
compared with transarterial chemoembolization (TACE) for patients with multiple …

Background: Post-treatment alpha-fetoprotein (AFP) response has been reported to be
associated with prognosis of hepatocellular carcinoma (HCC) patients, but the results were …

Background and aims So far, no randomized trial or meta-analysis has been conducted on
overall survival (OS) and recurrence-free survival (RFS) factors in patients treated with …

Prognosis of Early-Stage Hepatocellular Carcinoma: The Clini... : Medicine Prognosis of
Early-Stage Hepatocellular Carcinoma: The Clinical Implications of Substages of Barcelona …

AIM To investigate whether the change in pre-/post-operation serum alpha-fetoprotein (AFP)
levels is a predictive factor for hepatocellular carcinoma (HCC) outcomes. METHODS We …

Background and objective Recurrence of hepatocellular carcinoma (HCC) is an important
issue despite effective treatments with tumor eradication. Identification of patients who are at …